Monika Hitzl

1.2k total citations
12 papers, 1.0k citations indexed

About

Monika Hitzl is a scholar working on Oncology, Pediatrics, Perinatology and Child Health and Genetics. According to data from OpenAlex, Monika Hitzl has authored 12 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Pediatrics, Perinatology and Child Health and 2 papers in Genetics. Recurrent topics in Monika Hitzl's work include Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Hemoglobinopathies and Related Disorders (2 papers). Monika Hitzl is often cited by papers focused on Drug Transport and Resistance Mechanisms (9 papers), Pharmacological Effects and Toxicity Studies (8 papers) and Hemoglobinopathies and Related Disorders (2 papers). Monika Hitzl collaborates with scholars based in Germany, United States and Austria. Monika Hitzl's co-authors include Martin F. Fromm, Siegfried Drescher, Matthias Schwab, Michel Eichelbaum, Heiko van der Kuip, Michel Eichelbaum, Joachim E. Fischer, Elke Schäffeler, Elke Schaeffeler and Hartmut Glaeser and has published in prestigious journals such as Journal of Clinical Oncology, FEBS Letters and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Monika Hitzl

12 papers receiving 969 citations

Peers

Countries citing papers authored by Monika Hitzl

Since Specialization

Citations

This map shows the geographic impact of Monika Hitzl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Monika Hitzl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Monika Hitzl more than expected).

Fields of papers citing papers by Monika Hitzl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Monika Hitzl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Monika Hitzl. The network helps show where Monika Hitzl may publish in the future.

Co-authorship network of co-authors of Monika Hitzl

This figure shows the co-authorship network connecting the top 25 collaborators of Monika Hitzl. A scholar is included among the top collaborators of Monika Hitzl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Monika Hitzl. Monika Hitzl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Induction of Intestinal P-glycoprotein by St John's Wort Reduces the Oral Bioavailability of Talinolol 2007 ·Clinical Pharmacology & Therapeutics ·Ute I. Schwarz, (unknown), Reinhard Oertel, Stephan Miehlke, Eberhard Kuhlisch, Hartmut Glaeser, Monika Hitzl, George K. Dresser, R B Kim, Wilhelm Kirch	92
2	Effects of ursodeoxycholic acid on P-glycoprotein and cytochrome P450 3A4–dependent pharmacokinetics in humans 2006 ·Clinical Pharmacology & Therapeutics ·Laurent Becquemont, Hartmut Glaeser, Siegfried Drescher, Monika Hitzl, Nicolas Simon, Thomas E. Mürdter, Georg Heinkele, Ute Hofmann, Christof Schaefer, Oliver Burk	14
3	Genetic polymorphisms in the multidrug resistance-associated protein 3 (ABCC3, MRP3) gene and relationship to its mRNA and protein expression in human liver 2004 ·Pharmacogenetics ·Thomas Lang, Monika Hitzl, Oliver Burk, (unknown), (unknown), Reinhold Kerb, Kathrin Klein, Ulrich M. Zanger, Michel Eichelbaum, Martin F. Fromm	81
4	Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1) 2004 ·Pharmacogenetics ·Monika Hitzl, Elke Schaeffeler, Berthold Hocher, Torsten Slowinski, H Halle, Michel Eichelbaum, Peter Kaufmann, Péter Fritz, Martin F. Fromm, Matthias Schwab	105
5	Phase I study of the anti-neovascular agent MBT-0206 to evaluate safety and efficacy in patients with metastatic or advanced unresectable gastrointestinal cancer (GI cancer) 2004 ·Journal of Clinical Oncology ·Karsten Ridwelski, E. Kettner, J. Fahlke, K. Bartelheim, Monika Hitzl, B. Schulze, Robert Koeber, Uwe Michaelis, Kurt Naujoks, Michael Clemens	6
6	Phase I study of the anti-neovascular agent MBT-0206 to evaluate safety and efficacy in patients with metastatic or advanced unresectable gastrointestinal cancer (GI cancer) 2004 ·Journal of Clinical Oncology ·Karsten Ridwelski, E. Kettner, Jörg Fahlke, K. Bartelheim, Monika Hitzl, B. Schulze, Robert Koeber, Uwe Michaelis, Kurt Naujoks, Michael Clemens	3
7	Influence of Omeprazole on Multidrug Resistance Protein 3 Expression in Human Liver 2003 ·Journal of Pharmacology and Experimental Therapeutics ·Monika Hitzl, Kathrin Klein, Ulrich M. Zanger, Péter Fritz, Andreas K. Nüssler, P. Neuhaus, Martin F. Fromm	44
8	Untersuchungen zur Expression, Funktion und Regulation der ABC-Transporter P-Glykoprotein und Multidrug Resistance Protein 3 beim Menschen 2003 ·OPUS Publication Server of the University of Stuttgart (University of Stuttgart) ·Monika Hitzl	1
9	P‐glycoprotein‐mediated intestinal and biliary digoxin transport in humans 2003 ·Clinical Pharmacology & Therapeutics ·Siegfried Drescher, Hartmut Glaeser, Thomas E. Mürdter, Monika Hitzl, Michel Eichelbaum, Martin F. Fromm	120
10	MDR1 gene polymorphisms and disposition of the P‐glycoprotein substrate fexofenadine 2002 ·British Journal of Clinical Pharmacology ·Siegfried Drescher, Elke Schaeffeler, Monika Hitzl, Ute Hofmann, Matthias Schwab, Ulrich Brinkmann, Michel Eichelbaum, Martin F. Fromm	214
11	A mutation in the β interaction domain of the Ca²⁺ channel α_1C subunit reduces the affinity of the (+)‐[³H]isradipine binding site 2002 ·FEBS Letters ·Monika Hitzl, Jörg Striessnig, Birgit Neuhuber, Bernhard E. Flucher	5
12	The C3435T mutation in the human MDR1 gene is associated with altered efflux of the P-glycoprotein substrate rhodamine 123 from CD56+ natural killer cells 2001 ·Pharmacogenetics ·Monika Hitzl, Siegfried Drescher, Heiko van der Kuip, Elke Schäffeler, Joachim E. Fischer, Matthias Schwab, Michel Eichelbaum, Martin F. Fromm	318

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact